Global Dermatological Drug Market - Forecasts from 2018 to 2023

Global Dermatological Drug Market - Forecasts from 2018 to 2023

The global dermatological drug market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. The demand for dermatological drugs is rising due to growing skin diseases, rising disposable and out-of-pocket incomes and growing awareness regarding skin health. Common medications for skin indications include antibacterial, anthralin, antifungals, retinoids and many more.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global dermatological drug value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global dermatological drug market.

Major industry players profiled as part of the report are AbbVie Inc., Curatio Healthcare, Sienna Biopharmaceuticals, Glenmark and NovaBay Pharmaceuticals, Inc. among others.

Segmentation

The global dermatological drug market has been analyzed through following segments:

By Indication 

Psoriasis

Acne

Dermatitis

Others


By Route of Administration

Topical

Oral

Parenteral


By End User

Hospitals and Clinics

Cosmetic Centers

Others


By Geography

North America

USA

Canada

Mexico

Others

 

South America

Brazil

Argentina

Others

 

Europe

Germany

France

United Kingdom

Spain

Others

 

Middle East and Africa

Saudi Arabia

Israel

Others

 

Asia Pacific

China

Japan

South Korea

India

Others


 

Target audience

Manufacturers

Suppliers

Distributors

Service Providers

Government Agencies

Research Organizations

Consultants


Key insights offered

What will be the global dermatological drug market size from 2017 to 2023?

How are the major drivers and restraints affecting the global dermatological drug market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY  
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL DERMATOLOGICAL DRUG MARKET BY INDICATION
5.1. Psoriasis
5.2. Acne
5.3. Dermatitis
5.4. Others
6. By Route of Administration
6.1. Topical 
6.2. Oral
6.3. Parenteral
7. By End User 
7.1. Hospitals and Clinics
7.2. Cosmetic Centers
7.3. Others
8 GLOBAL DERMATOLOGICAL DRUG MARKET BY GEOGRAPHY
8.1 North America
8.1.1 USA
8.1.2 Canada
8.1.3 Mexico
8.1.4 Others
8.1. South America
8.2.1 Brazil
8.2.2 Argentia
8.2.3 Others
8.2. Europe
8.3.1 Germany
8.3.2 France
8.3.3 United Kingdom
8.3.4 Spain
8.3.5 Others
8.3. Middle East and Africa
8.3.1. Saudi Arabia
8.3.2. Israel
8.3.3. Others
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. South Korea
8.4.4. India
8.4.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share of Key Players
9.2. Recent Investment and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. AbbVie Inc.
10.1.1. Company Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Recent Developments
10.2. Curatio Healthcare
10.2.1. Company Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Recent Developments
10.3. Sienna Biopharmaceuticals
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Recent Developments
10.4. Glenmark
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Recent Developments
10.5. NovaBay Pharmaceuticals, Inc.
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Recent Developments
10.6. THESAN PHARMACEUTICAL INC.
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Recent Developments
10.7. Vyome Biosciences
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Recent Developments
10.8. Aclaris Therapeutics, Inc.
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Recent Developments
10.9. Bausch Health Companies Inc.
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products and Services
10.9.4. Recent Developments
10.10. Galderma
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products and Services
10.10.4. Recent Developments
LIST OF FIGURES
LIST OF TABLES
DISCLAIMER 

AbbVie Inc.

Curatio Healthcare

Sienna Biopharmaceuticals

Glenmark

NovaBay Pharmaceuticals, Inc.

THESAN PHARMACEUTICAL INC.

Vyome Biosciences

Aclaris Therapeutics, Inc.

Bausch Health Companies Inc.

Galderma

  • SKU:
  • Publishing Date: 2018-11-23
  • Product Code: 1
  • Availability: In Stock
  • $3,800.00
  • Ex Tax: $3,800.00

Available Options